# Second Affiliated Hospital, Zhejiang University, School of Medicine: Phase 3 study started recruiting, 2832 planned (HFpEF - Heart Failure With Preserved Ejection Fraction, TAVI(Transcatheter Aortic Valve Implantation))

**Score:** 60/100

| Field | Value |
|---|---|
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Sponsor type | Academic and hospital |
| Study | Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure |
| NCT ID | NCT07575672 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | HFpEF - Heart Failure With Preserved Ejection Fraction; TAVI(Transcatheter Aortic Valve Implantation); Finerenone |
| Intervention types | drug |
| Target enrollment | 2832 |
| Site countries | China |
| Posted | 2026-05-08 |
| Planned start | 2026-10-09 |
| Event | Started recruiting |
| Event date | 2026-10-09 |
| Last update posted | 2026-10-16 |

## Why this score
- Just started recruiting: sites, recruitment and supply are active.
- Phase 3: multi-site, larger budget.
- 2832 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07575672). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.